US Patent Issued to AskGene Pharma on Aug. 25 for "Angiopoietin 2, VEGF dual antagonists" (California Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,912, issued on Aug. 25, was assigned to AskGene Pharma Inc. (Camarillo, Calif.).

"Angiopoietin 2, VEGF dual antagonists" was invented by Yuefeng Lu (Newbury Park, Calif.) and Jian-Feng Lu (Oak Park, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to chimeric molecules which are fusion proteins comprising two components: an Ang-2 binding peptide linked to either a VEGF antibody or a VEGF receptor-Fc fusion protein. The Ang2 peptide, VEGF antibody, and VEGF receptor-Fc fusion proteins are each defined below with reference to percent identity to a reference sequence. The chimeric molecule is a fusion protein, dual a...